Marilena Vrana: What An Inspiring Week at The 2025 Plasma Protein Forum and Business Forum
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”What an inspiring week at the 2025 Plasma Protein Forum and Business Forum.
The speaker lineup delivered a wealth of insights into how the plasma sector is evolving amid rapidly changing operating environments.
Across three days, discussions ranged from:
- Changing trade policies and their impact on supply chain resilience
- Harnessing real-world data to enhance donor safety
- Aligning regulatory frameworks to improve plasma collection and ensure consistent product quality
- The rising role of AI in every part of the value chain
One standout session focused on anti-D plasma collection.
Patients, donors and clinical experts shared their experiences and highlighted what it will take to expand access in anti-D immunoglobulin, a life-saving therapy for mothers and newborns.
Ben, a dedicated plasma donor, summed it up powerfully: “The stories keep motivating me to come back and keep donating.”
His donations alone helped provide over 52,800 doses of this critical therapy – a testament to the extraordinary impact one individual can have.
His reminder that “word-of-mouth is huge” is a call to all of us to keep raising awareness!
The momentum in this sector is stronger than ever and collaboration will be key to unlocking what comes next.
For those who attended:
- What sessions or discussions made the biggest impression?
- Which topics should carry forward to IPPC 2026 in Milan?
Let’s keep the conversation going!”
Stay updated with Hemostasis Today.
-
Oct 18, 2025, 16:59Raul Santos Gave 2 Talks at SAC 2025: On The Role of LDL-C and Future of Lipid-lowering Therapies
-
Oct 18, 2025, 16:57Marilena Vrana: What An Inspiring Week at The 2025 Plasma Protein Forum and Business Forum
-
Oct 18, 2025, 16:53Caitlin Raymond: When Technology Meets Physiology in Neonatal Patients
-
Oct 17, 2025, 08:37Salome Mekhuzla Invites You to Join WHO Essential Medicines List 2025 Updates Webinar on Hemophilia and VWD
-
Oct 17, 2025, 08:36Plasma Protein Forum 2025: From Anti-D Plasma and Blood Supply Incentives to the Future of AI
-
Oct 18, 2025, 16:56Alexandra Whiteside on Improving Coagulation Kinetics
-
Oct 18, 2025, 16:52Wolfgang Miesbach on Differential Diagnosis of Thrombocytopenia
-
Oct 18, 2025, 16:49Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert on Management of Thrombosis in Behçet’s Syndrome
-
Oct 18, 2025, 16:47State of the Art Review On Angina After PCI From Javier Escaned's Team
-
Oct 18, 2025, 16:25Luciana Werneck Zuccherato and Colleagues on A3 domain of FVIII in Severe Hemophilia A
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 13, 2025, 04:48Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 18, 2025, 16:55Emilia Arturo: Your Reminder to Donate Blood If You Can, When You Can
-
Oct 18, 2025, 16:51Allison Wheeler Rallies Support for Magdalena Lewandowska's NYC Marathon Run Benefiting NBDF
-
Oct 17, 2025, 16:07WFH Volunteer Mary Byrne Transforms Bleeding Disorder Diagnostics
-
Oct 17, 2025, 08:52Erica Sparkenbaugh: Shout Out to My Doctoral Student Kylie Hutchison for Her Outstanding Oral Presentation
-
Oct 17, 2025, 08:45Shamee Shastry Shares Lean and Six Sigma in Transfusion Medicine Training Program's Success